nirmatrelvir
Showing 1 - 8 of 8
Long COVID Trial (Nirmatrelvir, Ritonavir, Placebo)
Not yet recruiting
- Long COVID
- Nirmatrelvir
- +2 more
- (no location specified)
Dec 24, 2022
COVID-19 Trial in United States (Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir)
Not yet recruiting
- COVID-19
- Nirmatrelvir
- +3 more
-
Miami, Florida
- +2 more
Jul 21, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
-
Cooperstown, New York
- +10 more
Dec 11, 2022
Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID Trial in Stanford (Nirmatrelvir, Placebo, Ritonavir)
Recruiting
- Post-acute Sequelae of SARS-CoV-2 Infection
- Long COVID
- Nirmatrelvir
- +2 more
-
Stanford, CaliforniaStanford University
Dec 12, 2022
COVID-19 Trial in Canada, Taiwan, United States (nirmatrelvir, ritonavir, for nirmatrelvir)
Recruiting
- COVID-19
- nirmatrelvir
- +2 more
-
Mesa, Arizona
- +43 more
Dec 29, 2022